Skip to main content

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Investor Securities Class Action Lawsuit 12/20/2021

  • You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of April 24, 2024, by which all claims must be submitted. The instructions for submitting are included in the "Proof" and the "Notice" files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 27, 2023 - The court granted preliminary approval of the settlement. October 30, 2023 - The parties entered into a stipulation of settlement. September 14, 2023 - The court denied the pending motion to dismiss as moot. July 31, 2023 - The parties notified the court that they had reached an agreement in principle to settle the case. September 7, 2022 - A motion was filed to di...

You must register (for free) or login to view the entire case.